EQT sells its remaining stake in Galderma Group AG, marking a historic trade.

  • EQT exits Galderma Group AG fully.
  • The exit involved the largest sponsor-backed block trade to date.
  • EQT Partners played a key role in the transaction.

EQT has announced the full exit of its investment in Galderma Group AG, conducting this divestiture through a landmark block trade. This transaction has been recognized as the largest sponsor-backed block trade in history. This move illustrates EQT's strategic focus on optimizing its investment portfolio.

The block trade was executed in collaboration with a leading global investment bank, securing a substantial amount from the sale. This step follows EQT's investment in Galderma, which specializes in dermatology-related products, demonstrating the firm's commitment to strategic exits that optimize shareholder value. EQT Partners has played a crucial role in managing this significant transaction.

Since its investment, EQT has supported Galderma's growth and expansion within the dermatological market. Completing this exit further underlines the firm's strategy to focus on high-potential investments while ensuring successful transitions for their portfolio companies.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Services PMI at 53.8 in January 2026, According to ISM Report

January sees strong growth in services sector as PMI remains robust. Services…

Pharmacelera Raises $6M to Expand in US and Enhance Drug Discovery Platform

Funding will support growth and technological advancements in drug discovery. Pharmacelera has…

NUNM Receives $1.5 Million Gift to Support Campus Expansion and Future Integrative Medicine Center

Major donation aims to enhance educational opportunities at NUNM. NUNM receives a…

WuXi Biologics and Vertex Enter Research Agreement for T-Cell Engager

Collaboration focuses on advancing T-cell engager therapies for cancer treatment WuXi Biologics…